Artwork

Content provided by Laila Maijet. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Laila Maijet or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Drug trial shows injection twice a year is 100% effective against infection

22:53
 
Share
 

Manage episode 428011254 series 2579897
Content provided by Laila Maijet. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Laila Maijet or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Lerato Mbele speaks to Dr Katherine Gill, a Clinical Research Lead at the Desmond Tutu Health Foundation about South Africa and Uganda's clinical trials which have shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other pre-exposure drugs, both daily pills.

See omnystudio.com/listener for privacy information.

  continue reading

351 episodes

Artwork
iconShare
 
Manage episode 428011254 series 2579897
Content provided by Laila Maijet. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Laila Maijet or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Lerato Mbele speaks to Dr Katherine Gill, a Clinical Research Lead at the Desmond Tutu Health Foundation about South Africa and Uganda's clinical trials which have shown that a twice-yearly injection of a new pre-exposure prophylaxis drug gives young women total protection from HIV infection. The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other pre-exposure drugs, both daily pills.

See omnystudio.com/listener for privacy information.

  continue reading

351 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide